DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgeryReport as inadecuate




DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery - Download this document for free, or read online. Document in PDF available to download.

Background

The 2016 WHO histopathological grade or conventional biomarker MIB-1 is insufficient for predicting meningioma recurrence after initial treatment and alternative strategies are required. In this study, we investigated whether DNA topoisomerase IIα and-or mitosin expression can predict tumor recurrence with greater accuracy than conventional methods.

Methods

The expression of MIB-1, topoisomerase IIα, and mitosin were determined as proliferation indices in tissue microarrays using immunohistochemistry. The accuracy of prognostication was assessed with receiver operating characteristic ROC analyses and standard survival analyses.

Results

Expression of topoisomerase IIα and mitosin was significantly higher in recurrent meningioma than in non-recurrent meningioma P ≤ 0.031, but no difference in MIB-1 expression was observed P = 0.854. ROC analysis found topoisomerase IIα and mitosin expression to be the most reliable predictors of recurrence compared to WHO histopathological grade and MIB-1 expression. This result was supported by the multivariate survival analysis, in which mitosin expression was a significant predictor of recurrence-free survival P < 0.001 and no association was found with histopathological grade or MIB-1 expression P ≥ 0.158.

Conclusions

The results suggest that topoisomerase IIα and mitosin improve prognostication of patients resected for meningioma. Tumors with higher topoisomerase IIα and-or mitosin expression have a higher risk of recurrence after initial treatment, and these patients may benefit from adjuvant treatment and closer radiological follow-up.



Author: Theo L. Winther , Sverre H. Torp

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents